The cellular kinase binding motifs (PxxP and RR) in human immunodeficiency virus type 1 Nef protein are dispensable for producer-cell- dependent enhancement of viral entry

Virology

Volumn 257, Issue 2, 1999, Pages 285-289

  Tokunaga, Kenzo ^a   Ikuta, Kazuyoshi ^b   Adachi, Akio ^c   Matsuda, Michiyuki ^d   Kurata, Takeshi ^a   Kojima, Asato ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

^d NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; NEF PROTEIN; PROLINE; PROTEIN KINASE P60; PROTEIN SERINE THREONINE KINASE;

ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FAMILY; VIRUS CELL INTERACTION; VIRUS INFECTIVITY; VIRUS MUTATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0033541963     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9682     Document Type: Article

References (31)

1. Adachi A., Gendelman H. E., Koenig S., Folks T., Willey R., Rabson A., Martin M. A. Production of acquired immunodeficiency syndrome-associated retrovirus in human and non-human cells transfected with an infectious molecular clone. J. Virol. 59:1986;284-291.
2. Adachi A., Ono N., Sakai H., Ogawa K., Shibata R., Kiyomasu T., Masuike H., Ueda S. Generation and characterization of the human immunodeficiency virus type 1 mutants. Arch. Virol. 117:1991;45-58.
3. Aiken C., Krause L., Chen Y. L., Trono D. Mutational analysis of HIV-1 Nef: Identification of two mutants that are temperature-sensitive for CD4 downregulation. Virology. 217:1996;293-300.
4. Aiken C., Trono D. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J. Virol. 69:1995;5048-5056.
5. Aldrovandi G. M., Gao L., Bristol G., Zack J. A. Regions of human immunodeficiency virus type 1nef. J. Virol. 72:1998;7032-7039.
6. Chowers M. Y., Spina C. A., Kwoh T. J., Fitch N. J. S., Richman D. D., Guatelli J. C. Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intactnef. J. Virol. 68:1994;2906-2914.
7. Graham F. L., Van der Eb A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 52:1973;456-467.
8. Hua J., Blair W., Truant R., Cullen B. R. Identification of regions in HIV-1 Nef required for efficient downregulation of cell surface CD4. Virology. 231:1997;231-238.
9. Jamieson B. D., Aldrovandi G. M., Planelles V., Jowett J. B. M., Gao L., Bloch L. M., Chen I. S. M., Zack J. A. Requirement of human immunodeficiency virus type 1nef. J. Virol. 68:1994;3478-3485.
10. Kawano Y., Tanaka Y., Misawa N., Tanaka R., Kira J. I., Kimura T., Fukushi M., Sano K., Goto T., Nakai M., Kobayashi T., Yamamoto N., Koyanagi Y. Mutational analysis of human immunodeficiency virus type 1 (HIV-1) accessory genes: Requirement of a site in the nef gene for HIV-1 replication in activated CD4+ T cells in vitro and in vivo. J. Virol. 71:1997;8456-8466.
11. Kestler H. W. III, Ringler D. J., Mori K., Panicali D. L., Sehgal P. K., Daniel M. D., Desrosiers R. C. Importance of thenef. Cell. 65:1991;651-662.
12. Khan I. H., Sawai E. T., Antonio E., Weber C. J., Mandell C. P., Montbriand P., Luciw P. A. Role of the SH3-ligand domain of simian immunodeficiency virus Nef in interaction with Nef-associated kinase and simian AIDS in rhesus macaques. J. Virol. 72:1998;5820-5830.
13. Kim S., Ikeuchi K., Byrn R., Groopman J., Baltimore D. Lack of a negative influence on viral growth by thenef. Proc. Natl. Acad. Sci. USA. 86:1989;9544-9548.
14. Kimpton J., Emerman M. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J. Virol. 66:1992;2232-2239.
15. Lang S. M., Iafrate A. J., Stahl-Hennig C., Kuhn E. M., Nisslein T., Kaup F. J., Haupt M., Hunsmann G., Skowronski J., Kirchhoff F. Association of simian immunodeficiency virus Nef with cellular serine/threonine kinases is dispensable for the development of AIDS in rhesus macaques. Nat. Med. 3:1997;860-865.
16. Luo T., Garcia J. V. The association of Nef with a cellular serine/threonine kinase and its enhancement of infectivity are viral isolate dependent. J. Virol. 70:1996;6493-6496.
17. Luo T., Livingston R. A., Garcia J. V. Infectivity enhancement by human immunodeficiency virus type 1 Nef is independent of its association with a cellular serine/threonine kinase. J. Virol. 71:1997;9524-9530.
18. Marechal V., Clavel F., Heard J. M., Schwartz O. Cytosolic Gag p24 as an index of productive entry of human immunodeficiency virus type 1. J. Virol. 72:1998;2208-2212.
19. Miller M. D., Warmerdam M. T., Gaston I., Greene W. C., Feinberg M. B. The human immunodeficiency virus type 1nef. J. Exp. Med. 179:1994;101-113.
20. Saksela K., Cheng G., Baltimore D. Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J. 14:1995;484-494.
21. Salter R. D., Howell D. N., Cresswell P. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics. 21:1985;235-248.
22. Sawai E. T., Khan I. H., Montbriand P. M., Peterlin B. M., Cheng-Mayer C., Luciw P. A. Activation of PAK by HIV and SIV Nef: Importance for AIDS in rhesus macaques. Curr. Biol. 6:1996;1519-1527.
23. Schwartz O., Marechal V., Danos O., Heard J.-M. Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cells. J. Virol. 69:1995;4053-4059.
24. Shibata R., Kawamura M., Sakai H., Hayami M., Ishimoto A., Adachi A. Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells. J. Virol. 65:1991;3514-3520.
25. Spina C. A., Kwoh T. J., Chowers M. Y., Guatelli J. C., Richman D. D. The importance ofnef. J. Exp. Med. 179:1994;115-123.
26. Swingler S., Gallay P., Camaur D., Song J., Abo A., Trono D. The Nef protein of human immunodeficiency virus type 1 enhances serine phosphorylation of the viral matrix. J. Virol. 71:1997;4372-4377.
27. Takai H., Ohmori H. DNA transfection of mouse lymphoid cells by the combination of DEAE-dextran-mediated DNA uptake and osmotic shock procedure. Biochim. Biophys. Acta. 1048:1990;105-109.
28. Tokunaga K., Kiyokawa E., Nakaya M., Otsuka N., Kojima A., Kurata T., Matsuda M. Inhibition of human immunodeficiency virus type 1 virion entry by dominant-negative Hck. J. Virol. 72:1998;6257-6259.
29. Tokunaga K., Kojima A., Kurata T., Ikuta K., Akari H., Koyama A. H., Kawamura M., Inubushi R., Shimano R., Adachi A. Enhancement of human immunodeficiency virus type 1 infectivity by Nef is producer cell-dependent. J. Gen. Virol. 78:1998;2447-2453.
30. Tokunaga K., Kojima A., Kurata T., Ikuta K., Inubushi R., Shimano R., Kawamura M., Akari H., Koyama A. H., Adachi A. Producer cell-dependent requirement of the Nef protein for efficient entry of HIV-1 into cells. Biochem. Biophys. Res. Commun. 250:1998;565-568.
31. Wiskerchen M., Cheng-Mayer C. HIV-1 Nef association with cellular serine kinase correlates with enhanced virion infectivity and efficient proviral DNA synthesis. Virology. 224:1996;292-301.